IsoRay Inc.

IsoRay Inc.
Stock Exchange NYSE
EPS
$0.1
Market Cap
$27.64 M
Shares Outstanding
67.34 M
Public Float
66.62 M

Profile

Address
350 Hills Street
Richland Washington 99354
United States
Employees -
Website http://www.isoray.com
Updated 07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.

Financials

View All
Created with Highcharts 5.0.14IsoRay Inc.Net Income. Fiscal year is July-June. All values USD Thousands.3 8563 8565 9595 9593 6813 6814 7104 7106 1626 1626 7006 70020132014201520162017201802k4k6k8k
Created with Highcharts 5.0.14IsoRay Inc.Sales/Revenue. Fiscal year is July-June. All values USD Thousands.4 5254 5254 2194 2194 6064 6064 7694 7694 7614 7615 9235 92320132014201520162017201801k2k3k4k5k6k7k

Lori A. Woods
Chief Executive Officer & Director
Michael W. McCormick
Chairman